Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 2/2017

01-02-2017 | Maternal-Fetal Medicine

MR pelvimetry: prognosis for successful vaginal delivery in patients with suspected fetopelvic disproportion or breech presentation at term

Authors: Marie Franz, Amanda von Bismarck, Maria Delius, Birgit Ertl-Wagner, Charlotte Deppe, Sven Mahner, Uwe Hasbargen, Christoph Hübener

Published in: Archives of Gynecology and Obstetrics | Issue 2/2017

Login to get access

Abstract

Purpose

The purpose of this study was to correlate MR pelvimetric pelvic inlet measurements with mode of delivery and neonatal outcome in patients with suspected fetopelvic disproportion or breech presentation.

Methods

For this retrospective monocentric study, 237 consecutive MR pelvimetry reports (1999–2016) of pregnant women due to either suspected fetopelvic disproportion, pelvic deformation after trauma, or persistent breech presentation were retrieved from the radiologic database and matched with corresponding information from the obstetric database.

Results

Of 223 included women, 95 (42.6%) underwent planned cesarean section (pCS) and 128 (57.4%) underwent a trial of vaginal labour (TOL), of whom 93 (72.7%) delivered vaginally. Vaginal delivery was successful in 45 out of 64 (70.3%) cephalic cases and in 48 out of 64 (75.0%) breech cases. We found statistically significant differences in conjugata vera obstetrica (CV) and diameter transversalis (DT) between the groups TOL and pCS (CV: 12.5 ± 1.0 vs 12.1 ± 1.2 cm, p value 0.001; DT: 13.3 ± 0.9 vs 12.7 ± 0.9 cm, p value <0.001, respectively). However, there was no significant difference between successful VD and cesarean section after TOL (CV: 12.5 ± 0.9 vs 12.3 ± 1.1 cm, p value 0.194; DT: 13.4 ± 0.9 vs 13.2 ± 0.9 cm, p value 0.358, respectively).

Conclusions

In our cohort, MR pelvimetry was a useful tool for prepartal assessment of the female pelvis in the selection of TOL candidates. Yet, it does not seem to yield additional predictive value for women with a previous vaginal delivery.
Literature
1.
Stark DD, McCarthy SM, Filly RA, Parer JT, Hricak H, Callen PW (1985) Pelvimetry by magnetic resonance imaging. Am J Roentgenol 144(5):947–950CrossRef
2.
Kikuchi S, Saito K, Takahashi M, Ito K (2010) Temperature elevation in the fetus from electromagnetic exposure during magnetic resonance imaging. Phys Med Biol 55(8):2411–2426CrossRefPubMed
3.
Baker PN, Johnson IR, Harvey PR, Gowland PA, Mansfield P (1994) A 3-year follow-up of children imaged in utero with echo-planar magnetic resonance. Am J Obstet Gynecol 170(1 Pt 1):32–33CrossRefPubMed
4.
Patenaude Y, Pugash D, Lim K, Morin L, Diagnostic Imaging C, Lim K, Bly S, Butt K, Cargill Y, Davies G, Denis N, Hazlitt G, Morin L, Naud K, Ouellet A, Salem S, Society of Obstetricians and Gynaecologists of Canada (2014) Gynaecologists of, The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can 36(4):349–363CrossRefPubMed
5.
Strizek B, Jani JC, Mucyo E, De Keyzer F, Pauwels I, Ziane S, Mansbach AL, Deltenre P, Cos T, Cannie MM (2015) Safety of MR imaging at 1.5 T in fetuses: a retrospective case–control study of birth weights and the effects of acoustic noise. Radiology 275(2):530–537CrossRefPubMed
6.
van Loon AJ, Mantingh A, Thijn CJ, Mooyaart EL (1990) Pelvimetry by magnetic resonance imaging in breech presentation. Am J Obstet Gynecol 163(4 Pt 1):1256–1260CrossRefPubMed
7.
Wentz KU, Lehmann KJ, Wischnik A, Lange S, Suchalla R, Gronemeyer DH, Seibel RM (1994) Pelvimetry using various magnetic resonance tomography techniques vs. digital image enhancement radiography: accuracy, time requirement and energy exposure. Geburtshilfe Frauenheilkd 54(4):204–212CrossRefPubMed
8.
Ferguson JE 2nd, Sistrom CL (2000) Can fetal-pelvic disproportion be predicted. Clin Obstet Gynecol 43(2):247–264CrossRefPubMed
9.
Harper LM, Odibo AO, Stamilio DM, Macones GA (2013) Radiographic measures of the mid pelvis to predict cesarean delivery. Am J Obstet Gynecol 208(6):460 e1–460 e6CrossRef
10.
Korhonen U, Taipale P, Heinonen S (2015) Fetal pelvic index to predict cephalopelvic disproportion—a retrospective clinical cohort study. Acta Obstet Gynecol Scand 94(6):615–621CrossRefPubMed
11.
Berger R, Sawodny E, Bachmann G, Herrmann S, Kunzel W (1994) The prognostic value of magnetic resonance imaging for the management of breech delivery. Eur J Obstet Gynecol Reprod Biol 55(2):97–103CrossRefPubMed
12.
van Loon AJ, Mantingh A, Serlier EK, Kroon G, Mooyaart EL, Huisjes HJ (1997) Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term. Lancet 350(9094):1799–1804CrossRefPubMed
13.
Sporri S, Thoeny HC, Raio L, Lachat R, Vock P, Schneider H (2002) MR imaging pelvimetry: a useful adjunct in the treatment of women at risk for dystocia? Am J Roentgenol 179(1):137–144CrossRef
14.
Fox LK, Huerta-Enochian GS, Hamlin JA, Katz VL (2004) The magnetic resonance imaging-based fetal-pelvic index: a pilot study in the community hospital. Am J Obstet Gynecol 190(6):1679–1685 (discussion 1685–8) CrossRefPubMed
15.
Stalberg K, Bodestedt A, Lyrenas S, Axelsson O (2006) A narrow pelvic outlet increases the risk for emergency cesarean section. Acta Obstet Gynecol Scand 85(7):821–824CrossRefPubMed
16.
Zaretsky MV, Alexander JM, McIntire DD, Hatab MR, Twickler DM, Leveno KJ (2005) Magnetic resonance imaging pelvimetry and the prediction of labor dystocia. Obstet Gynecol 106(5 Pt 1):919–926CrossRefPubMed
17.
Maharaj D (2010) Assessing cephalopelvic disproportion: back to the basics. Obstet Gynecol Surv 65(6):387–395CrossRefPubMed
18.
Jeyabalan A, Larkin RW, Landers DV (2005) Vaginal breech deliveries selected using computed tomographic pelvimetry may be associated with fewer adverse outcomes. J Matern Fetal Neonatal Med 17(6):381–385CrossRefPubMed
19.
Vistad I, Cvancarova M, Hustad BL, Henriksen T (2013) Vaginal breech delivery: results of a prospective registration study. BMC Pregnancy Childbirth 13:153CrossRefPubMedPubMedCentral
20.
21.
Korhonen U, Taipale P, Heinonen S (2014) The diagnostic accuracy of pelvic measurements: threshold values and fetal size. Arch Gynecol Obstet 290(4):643–648CrossRefPubMed
22.
McMaster-Fay RA (2015) Managing the breech presentation at term: the place of pelvimetry. Aust N Z J Obstet Gynaecol 55(1):99CrossRefPubMed
23.
24.
Griffiths M (1998) Magnetic-resonance pelvimetry in breech presentation. Lancet 351(9106):912 (author reply 913) CrossRefPubMed
25.
Bisits A (2015) The value of imaging pelvimetry in the management of the breech presentation at term. Aust N Z J Obstet Gynaecol 55(1):99–100CrossRefPubMed
26.
Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR (2000) Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 356(9239):1375–1383CrossRefPubMed
27.
28.
Korhonen U, Solja R, Laitinen J, Heinonen S, Taipale P (2010) MR pelvimetry measurements, analysis of inter- and intra-observer variation. Eur J Radiol 75(2):e56–e61CrossRefPubMed
29.
Tsvieli O, Sergienko R, Sheiner E (2012) Risk factors and perinatal outcome of pregnancies complicated with cephalopelvic disproportion: a population-based study. Arch Gynecol Obstet 285(4):931–936CrossRefPubMed
30.
Parissenti TK, Hebisch G, Sell W, Staedele PE, Viereck V, Fehr MK (2016) Risk factors for emergency caesarean section in planned vaginal breech delivery. Arch Gynecol Obstet. doi:10.​1007/​s00404-016-4190-y PubMed
31.
Vrouenraets FP, Roumen FJ, Dehing CJ, van den Akker ES, Aarts MJ, Scheve EJ (2005) Bishop score and risk of cesarean delivery after induction of labor in nulliparous women. Obstet Gynecol 105(4):690–697CrossRefPubMed
32.
Landon MB, Leindecker S, Spong CY, Hauth JC, Bloom S, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG, National Institute of Child, N. Human Development Maternal-Fetal Medicine Units (2005) The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol 193(3 Pt 2):1016–1023CrossRefPubMed
33.
Macharey G, Ulander VM, Heinonen S, Kostev K, Nuutila M, Vaisanen-Tommiska M (2015) Induction of labor in breech presentations at term: a retrospective observational study. Arch Gynecol Obstet 293(3):549–555CrossRefPubMed
Metadata
Title
MR pelvimetry: prognosis for successful vaginal delivery in patients with suspected fetopelvic disproportion or breech presentation at term
Authors
Marie Franz
Amanda von Bismarck
Maria Delius
Birgit Ertl-Wagner
Charlotte Deppe
Sven Mahner
Uwe Hasbargen
Christoph Hübener
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 2/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4276-6

Other articles of this Issue 2/2017

Archives of Gynecology and Obstetrics 2/2017 Go to the issue

Maternal-Fetal Medicine

Can we predict successful cervical ripening with prostaglandin E2 vaginal inserts?

Erratum

Erratum to: Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study

Gynecologic Endocrinology and Reproductive Medicine

Pregnancy outcomes in oocyte recipients with fibroids not impinging uterine cavity

Gynecologic Oncology

Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients

News and Views

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers

Maternal-Fetal Medicine

Maxillary length in euploid and aneuploid fetuses